Health Condition 1: L639- Alopecia areata, unspecified
Conditions
Interventions
Intervention1: Rovaan poshak Taila: . Rovaan poshak Taila will be applied locally for 10 minutes to the scalp keeping up overnight and rinse next morning thrice a week for 30 days. Follow up will be d
Sponsors
Multani Pharmaceuticals Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Subjects having diffuse hair fall Subjects willing to participate in the study Subjects able to provide signed ICF prior to any study related procedure
Exclusion criteria
Exclusion criteria: 1. Subjects below 18 years and above 45 years of age 2. Subjects on immunosuppressive drugs with evidence of skin infection 3. Subjects who had used any topical therapy for diffuse hair loss in the 2 weeks prior to the initiation of study 4. Individuals with immediate life threatening diseases such as pre-existing cardiovascular, liver or neoplastic diseases 5. Individuals who received any immunosuppressant, sedative, hypnotic or tranquilizer within 14 days prior to enrollment 6. Individuals with any psychiatric illness which may impair the ability to provide written ICF. 7. Individuals participating in any other clinical trial. 8. Pregnant and lactating females.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in Hair FallTimepoint: 45 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in quality of hairs and scalpTimepoint: 45 days | — |
Countries
India
Contacts
Public ContactDr Gulab pamnani
Multani Pharmaceuticals Ltd.
Outcome results
None listed